Floatz logo

Cipralex

Atypical Depressive Disorder

Duke UniversityPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Atypical Depressive Disorder cohort.

Asset / SponsorPhaseRating
Duloxetine
New York State Psychiatric Institute
Phase 4BB
Chromium Picolinate
Pennington Biomedical Research Center
N/AD

Same molecule, other indications

Cipralex is also rated in:

Anxiety DisordersDormant
A
Indicative ·
81 / 100
View asset →
bipolar I disorderDormant
BBB
Indicative ·
77 / 100
View asset →
dysthymic disorderDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →